English | Español
Amanda Rupp | Jun 1, 2016

FDA approves Zinbryta to treat MS
Kim Sunderland | Jun 1, 2016

Independent Women’s Forum policy expert says more diverse health insurance plans are needed across U.S.
Amanda Rupp | Jun 1, 2016

FDA approves new diagnostic imaging agent for recurrent prostate cancer
Amanda Rupp | Jun 1, 2016

Bristol-Myers Squibb responds to ICER report
Amanda Rupp | Jun 1, 2016

First buprenorphine implant treatment for opioid dependence earns FDA approval
Amanda Rupp | Jun 1, 2016

New CMS data initiatives to improve transparency of Medicare program

Trending
+ Community
Patient Daily | Apr 28, 2025

ENT Practice Expert: AOCOO-HNS Clinical Assembly will feature 'at least four sessions that seem particularly valuable for physicians'
+ Pharmaceuticals
Patient Daily | Apr 29, 2025

Eli Lilly boosts federal lobbying spend as it ups legal pressure on compound pharmacies
+ Pharmaceuticals
Patient Daily | Apr 29, 2025

Panorama reveals issues with baby food pouches in new investigation
+ Pharmaceuticals
Patient Daily | Apr 28, 2025

Alliance Pharmacy CEO on FDA compounded tirzepatide block: The data used is not 'enough to say the shortage is really over'